Lyell Immunopharma, Inc. (LYEL) stock
LYELNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.67−0.98 (-6.69%)
Close on Nov 17, 2026Market cap $334.99MP/E –Yield –
Lyell Immunopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Lyell Immunopharma's price to book ratio was 1.7× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 2.1×, with a median of 1.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | −0.1 |
| 2025 | Dec 31, 2025 | 1.8× | +1.5 |
| 2024 | Dec 31, 2024 | 0.3× | −0.4 |
| 2023 | Dec 29, 2023 | 0.7× | −0.4 |
| 2022 | Dec 30, 2022 | 1.1× | −0.8 |
| 2021 | Dec 31, 2021 | 1.9× | – |
See a number that looks wrong?